Othram utilizes proprietary KinSNP® analysis and DNASolves® database to identify human remains and resolve missing persons cases by overcoming forensic DNA barriers. The company partners with law enforcement agencies to provide in-house processing of DNA evidence, ensuring accurate identification and closure for families affected by unresolved cases.
Funding
$48.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
GFounders
Product
Problem
Traditional forensic DNA analysis methods often fail when dealing with degraded, limited, or mixed DNA samples, leaving many missing person and unidentified remains cases unresolved. This can leave families without closure and hinder law enforcement's ability to solve cold cases.
Solution
Othram provides advanced forensic DNA testing and analysis to identify human remains and solve missing persons cases where conventional methods have failed. The company utilizes proprietary DNA enrichment, sequencing, and KinSNP® analysis techniques to extract and analyze even the most challenging DNA samples. Othram's DNASolves® database and forensic genealogy expertise enable the identification of individuals by connecting distant relatives and building comprehensive family trees. By offering in-house processing of evidence, Othram maintains chain of custody and ensures secure, accountable handling of sensitive forensic materials.
Target Audience
Othram primarily serves law enforcement agencies, medical examiners, and forensic professionals working to identify human remains and solve missing persons or cold cases.
Features
- Proprietary KinSNP® analysis to digitize many types of genetic variation
- DNASolves® database for forensic genealogy and identification
- Advanced DNA extraction, enrichment, and repair techniques for degraded samples
- Mixture deconvolution to resolve complex DNA profiles
- In-house processing of evidence from extraction to sequencing
- Automatic human enrichment to increase the proportion of human DNA in the sample
- Separate unidirectional workflows to prevent contamination
- Upfront DNA profile feasibility assessment to avoid unnecessary evidence consumption